Kip Piper's Health Care Blog
Medicare, Medicaid, Health Reform

Medicare Episode-Based Payment Reform Demonstrations GAO Review of Voluntary and Mandatory Models

Medicare Episode-Based Payment Reform Demonstrations: GAO Review of Voluntary and Mandatory...

The Centers for Medicare and Medicaid Services (CMS) is investigating the effects of different episode-based payment methodologies on health care cost efficiency...

Opioid Recovery and Patient Access to Medication Assisted Treatment in Medicaid,...

For the 2.4 million Americans with an opioid use disorder, the over 10 million who abuse prescription opioids, and the nearly one million heroin...

Physician Payment Reform: Effects of New Payment Models on Physician Practices,...

How have alternative health care payment models, aimed at lowering costs while improving patient outcomes, affected physicians and physician practices in the United States?...

Managing Editor: Leroy Piper

Editor: Kip Piper

A national expert on Medicaid and Medicare, Kip Piper, MA, FACHE is a prominent consultant, speaker, and writer. Kip advises life sciences firms, major healthcare providers, state Medicaid agencies, health insurers, and investment firms. With 30 years’ federal, state, and private sector experience, Kip Piper is president of the Health Results Group, LLC, strategic advisory firm and CEO of Medonomics, Inc, a nonprofit research organization dedicated to improving healthcare value and decision making. For more, please visit KipPiper.com. Follow on Twitter @KipPiper. Connect on LinkedIn.

Stay Connected

4,901FansLike
7,208FollowersFollow
14,831FollowersFollow

Medistrategy Podcast

Medicare Episode-Based Payment Reform Demonstrations GAO Review of Voluntary and Mandatory Models

Medicare Episode-Based Payment Reform Demonstrations: GAO Review of Voluntary and Mandatory Models

The Centers for Medicare and Medicaid Services (CMS) is investigating the effects of...
Use of Medicines in 2019 and Forecasts for 2023 Drugs and Biologics

Use of Prescription Medicines Today and Forecasts for 2023: Valuable Market Insights from IQVIA

Biopharmaceutical Spending Increasing but at Slower Annual Growth Rate  The...
Real-World Evidence for Drugs, Biologics, Medical Diagnostics, and Devices. Blog post by Kip Piper.

Real-World Evidence in Medical Product Development: Drugs, Biologics, Diagnostics, and Devices

Insights from Experts Convened by the U.S. Food and Drug Administration (FDA)...
Physician Practice Patterns and Perspectives on Change: Insights from National Survey

Physician Practice Patterns and Perspectives on Change: Insights from National Survey

Physicians are in the midst of dramatic change, affecting practice patterns, care delivery models, payment...
Teen Hospital Stays for Childbirth Latest Trends

Teen Hospital Stays for Childbirth: Latest National and State Specific Trends

Teen pregnancy rates in the U.S. remain high with significant variation among states in both...

Opioid Recovery and Patient Access to Medication Assisted Treatment in Medicaid, Medicare Part D, and Private Health Insurance

For the 2.4 million Americans with an opioid use disorder, the over 10 million who...

Drug Pricing Reform: Understanding Indication Specific Pricing of Pharmaceuticals

Today, prices driving prescription drug spending are largely rooted in a long history of pricing...

High-Need, High-Cost Patients: Impact of Functional Limitations on Health Care Costs

Health care expenditures are three times greater for patients who have both functional limitations and...

Health Care Payment Reform: Strengths and Weaknesses of 9 Methods for Provider Reimbursement

Health care payment reform efforts focus on substituting cost-effective value for volume and ultimately aligning...

Access To Health Care

Opioid Recovery and Patient Access to Medication Assisted Treatment in Medicaid,...

For the 2.4 million Americans with an opioid use disorder, the over 10 million who abuse prescription opioids, and the nearly one million heroin...